Purpose: To assess the feasibility of real-time intraoperative treatment pl
anning for permanent prostate brachytherapy analyzing the impact on operati
ve time and adequacy of postimplant dosimetry.
Methods and Materials: Seventeen consecutive patients undergoing permanent
brachytherapy for prostate cancer had real-time intraoperative computer-bas
ed and optimized treatment planning. The first 8 patients were implanted us
ing a plan generated before the surgery and served to assure the team quali
tatively that this could be performed without greatly increasing intraopera
tive time. They served as control group for expected achieved dosimetry res
ults reviewing the D90, V100, V150 parameters from the dose-volume histogra
ms. The next 9 patients were implanted according to the real-time plan, The
times needed to carry out various steps of the procedure were recorded. Th
e achieved dosimetry was then compared to the control group to assure that
accuracy was unchanged.
Results: The median operative time for patients undergoing intraoperative d
osimetry was 57 min. Of this, 21 min were devoted to anesthesia and nursing
functions. Postoperative dosimetry showed a median achieved V100 (volume o
f prostate receiving 100% of prescribed dose) of 97% for the control group.
For the real-time dosimetry group, the median V100 was similar at 94%. The
V150 (volume receiving 150%) is 49% for both groups, The D90 (dose receive
d by 90% of the target) was normalized for easy comparison and,vas consiste
ntly slightly greater than the prescription dose.
Conclusion: Treatment planning for permanent brachytherapy of prostate canc
er has historically been performed as a computer-generated and optimized pl
an run weeks in advance of an implant, or according to a set pattern using
an intraoperative nomogram. These data show that planning can now be optimi
zed intraoperatively using widely available software without compromising t
he operative time or implant quality. (C) 2000 Elsevier Science Inc.